9th ISPAD Science School for Health Professionals in Istanbul, Turkey

It has become a tradition for dietitians, nurses, psychologists and social workers to meet before the annual ISPAD meeting to attend the ISPAD Science School for Health Professionals (SSHP). This is an international 3-day workshop providing some understanding of cutting-edge research methodologies in pediatric diabetes.

Changing Diabetes in Children training in Guinea

ISPAD is Changing Diabetes in Children in Conakry, Guinea

ISPAD 2012 Prizes and Fellowships

ISPAD's prizes for 2012 were presented at the annual meeting in Istanbul, Turkey. We thank all of you that have applied or nominated for these awards. The Prizes were awarded during the Istanbul Meeting.

2011 Global IDF/ISPAD Guideline for Diabetes in Childhood and Adolescence

The current guideline has been developed by the International Diabetes Federation and ISPAD in collaboration. We tried to develop a guideline that is sensitive to resource and cost-effectiveness issues by addressing this in different "Levels of care": Recommended care, Limited care and Comprehensive care.

We hope the guidelines will be widely consulted and will be used to:

ISPAD Clinical Practice Consensus Guidelines 2009 Compendium

The 2009 ISPAD Clinical Practice Consensus Guidelines have now been published as a compendium in a Supplement to Pediatric Diabetes. We thank the international writing teams for their efforts in writing and updating these guidelines. The editors have been: Ragnar Hanas, Kim Donaghue, Georgeanna Klingensmith and Peter GF Swift.

Click here to find the files.

Changing Diabetes in Children

Changing Diabetes in Children trainingIn collaboration with ISPAD, Novo Nordisk has developed a training manual specific to the diagnosis, treatment and organising of diabetes care for children in developing countries. The manual is available in English and French.

Life for a Child helps children with diabetes

The International Diabetes Federation's Life for a Child Programme currently supports the care of 4000 children in 26 countries worldwide. The programme meets the children's immediate needs (insulin, syringes, monitoring and education), builds local capacity and lobbies governments to establish sustainable solutions. Eli Lilly is the main provider of insulin for this program.